Anniversary of Spokane City Hall Signifies Key Milestone in the Green Building Industry and Highlights Company's Long-Standing Contribution to High Performance Glazing
PALO ALTO, Calif., Oct 26, 2010 (BUSINESS WIRE) -- Southwall Technologies Inc., the worldwide innovator of energy-saving films and glass products, today celebrates the 30-year anniversary of the world's first high performance glass installation, the City Hall in Spokane, Washington. Utilizing Southwall's Heat Mirror(R) insulating glass - the world's first commercially produced low-emissivity, or low-e, glass product - Spokane City Hall has delivered significant energy savings over the past three decades. This underscores the company's field-proven product durability and its pioneering role in improving the energy efficiency of residential and commercial glazing.
Southwall's Heat Mirror technology - in which one or more lightweight Heat Mirror films are suspended within an insulating glass unit to create multiple insulating cavities - was the first major breakthrough in insulating glass performance in over 100 years, an innovation chosen by Popular Science as one of the Top 100 Products of the Millennium. Utilizing a high performance suspended film with an advanced low-e coating that reflects heat back to its source, Heat Mirror insulating glass enables buildings like Spokane City Hall to realize superior insulation and solar control, lowering a home or building's carbon footprint while decreasing cooling and heating expenses by up to 30 percent.
"Founded 30 years ago in response to the oil embargo, Southwall has always had, and always will have, energy efficiency as its core philosophy," said Dennis Capovilla, president and chief executive officer of Southwall Technologies. "As we reflect on our past by honoring the anniversary of our project with Spokane City Hall, we look forward to another 30 years of continuing to deliver innovative, industry-proven, and cost-effective super-insulating glass -- glass that promises to take green building to the next level of energy efficiency performance."
Since its introduction to the market, Heat Mirror has been installed in thousands of homes and buildings worldwide, including all 6,500 windows in New York's Empire State Building saving $400,000 in annual operating costs as a key component of a major energy upgrade.
About Southwall Technologies
Southwall Technologies Inc. is recognized as a leader in the development and manufacture of high performance, energy-saving films and glass products that dramatically improve the energy efficiency of residential, commercial and automotive glass. Southwall is an ISO 9001:2000-certified manufacturer with customers in over 25 countries.
SOURCE: Southwall Technologies Inc.
Vantage Communications for Southwall Technologies
Brianna Swales, +1-843-576-4139
bswales@pr-vantage.com
Copyright Business Wire 2010
Comtex
Recent SWTX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:05:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:09:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:05:26 PM
- FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN • GlobeNewswire Inc. • 08/28/2024 10:30:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:36:23 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:34:23 AM
- SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 08/07/2024 10:30:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:01:45 PM
- SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors • GlobeNewswire Inc. • 07/29/2024 10:30:11 AM
- SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 • GlobeNewswire Inc. • 07/23/2024 11:00:02 AM
- Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm • PR Newswire (US) • 07/02/2024 04:49:00 PM
- SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN • GlobeNewswire Inc. • 07/01/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:07:38 PM
- SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/05/2024 11:00:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:37:20 PM
- SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:53:56 PM
- SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference • GlobeNewswire Inc. • 05/08/2024 11:00:27 AM
- SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates • GlobeNewswire Inc. • 05/02/2024 10:30:00 AM
- SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 05:31:32 PM
- SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 • GlobeNewswire Inc. • 04/18/2024 11:00:28 AM
- SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN • GlobeNewswire Inc. • 03/04/2024 11:30:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 10:16:11 PM
- SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors • GlobeNewswire Inc. • 02/29/2024 01:30:13 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM